tradmap

EYPT Eyepoint, Inc.

$4.57 -4.39%

Updated

Healthcare · Laboratory Analytical Instruments

Eyepoint, Inc. (EYPT) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $394 million. Shares last traded at $4.57, 76.8% below their 52-week high. Over the past year the stock is down 61.9%. Net profit margin is -977.5%, below the peer median of -1.7%. Revenue declined 27.5% year over year.

Market Cap
$394M
Shares Out
86.2M
EPS (TTM)
$-6.92
P/E Ratio
P/S Ratio
12.56
P/B Ratio
2.37
Dividend / Share
Dividend Yield
52-Week High
$19.70
52-Week Low
$3.98
Volume
119,535
Avg Vol (3m)
146,629.508

Performance

1W
-0.87%
1M
-62.63%
3M
-62.71%
6M
-71.02%
YTD
-73.86%
1Y
-61.88%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
29.88
SMA (50)
$10.97
SMA (200)
$13.68
Price vs SMA50
-58.35%
Price vs SMA200
-66.58%
ATR (14)
$1.01

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$31M
Net Income
$-307M
Gross Margin
Operating Margin
Net Margin
-977.5%
Return on Equity
-184.3%
Return on Assets
-134.4%
Current Ratio
4.50
Debt / Equity
0.00
Revenue Growth (YoY)
-27.5%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 $-2.08 2026-08-05
Q1 2026 $-0.99 2026-05-07
FY 2025 $-3.17 2026-03-05
Q3 2025 $-2.35 2025-11-06
Q2 2026 $-1.50 2026-08-05
Q1 2026 $-0.65 2026-05-07

Full earnings history →

Laboratory Analytical Instruments peers

EYPT vs 14 industry peers (Laboratory Analytical Instruments), by market cap. Updated

P/S vs peers
12.56 / 5.01 med
+151% premium
Net margin vs peers
-977.5% / -1.7% med
below median
1–14 of 14
AAgilent Technologies$42.3B29.355.7319.5%-0.93%
WATWaters Corporation$40.6B63.248.7513.8%+0.36%
ILMNIllumina, Inc.$33.5B40.587.4518.4%+3.90%
MTDMettler Toledo$27.2B30.016.5821.9%-0.77%
RVTYRevvity$14.6B61.375.018.2%-0.24%
BIOBio-Rad Laboratories, Inc.$10.4B46.814.028.6%-0.19%
AVTRAvantor, Inc.$10.4B-18.811.58-8.4%+3.65%
BRKRBruker Corp$9.1B-127.122.59-2.0%+0.61%
TXG10x Genomics, Inc.$8.2B-108.5013.21-12.2%+2.45%
ALMRAlamar Biosciences, Inc.$2.1B+0.51%
CTKBCytek Biosciences, Inc.$611M-9.182.96-32.2%+0.21%
MASS908 Devices Inc.$414M-11.956.81-57.0%-3.05%
PACBPacific Biosciences Of California, Inc.$403M-3.06-1.52%
EYPTEyepoint, Inc.$394M-1.28-4.39%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.